Morphine Recruiting Phase 2 Trials for Interstitial Lung Disease (ILD) / Chronic Obstructive Pulmonary Disease (COPD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03824834Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness